The activated CAFs can still take up the EVs from CRC cells and undergo lipid metabolic reprogramming, which promotes the secretion of EVs through the CXCL5-CXCR2 axis and forms a positive-feedback loop, thereby aiding in the CRC growth and metastasis [13]. The gene discussed is CXCL5; the disease is colorectal carcinoma.